Your browser doesn't support javascript.
loading
Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel Disease.
Chaparro, M; Garre, A; Guerra Veloz, M F; Vázquez Morón, J M; De Castro, M L; Leo, E; Rodriguez, E; Carbajo, A Y; Riestra, S; Jiménez, I; Calvet, X; Bujanda, L; Rivero, M; Gomollón, F; Benítez, J M; Bermejo, F; Alcaide, N; Gutiérrez, A; Mañosa, M; Iborra, M; Lorente, R; Rojas-Feria, M; Barreiro-de Acosta, M; Kolle, L; Van Domselaar, M; Amo, V; Argüelles, F; Ramírez, E; Morell, A; Bernardo, D; Gisbert, J P.
Affiliation
  • Chaparro M; Gastroenterology Units from Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa [IIS-IP] and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas [CIBERehd], Madrid, Spain.
  • Garre A; Gastroenterology Units from Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa [IIS-IP] and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas [CIBERehd], Madrid, Spain.
  • Guerra Veloz MF; Gastroenterology Units from Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Vázquez Morón JM; Gastroenterology Units from Hospital Juan Ramón Jiménez, Huelva, Spain.
  • De Castro ML; Gastroenterology Units from Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
  • Leo E; Gastroenterology Units from Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Rodriguez E; Gastroenterology Units from Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • Carbajo AY; Gastroenterology Units from Hospital Universitario Río Hortega, Valladolid, Spain.
  • Riestra S; Gastroenterology Units from Hospital Universitario Central de Asturias and ISPA, Asturias, Spain.
  • Jiménez I; Gastroenterology Units from Hospital de Galdakao-Usansolo, Vizcaya, Spain.
  • Calvet X; Gastroenterology Units from Consorcí Corporació Sanitària Parc Tauli de Sabadell and CIBERehd, Barcelona, Spain.
  • Bujanda L; Gastroenterology Units from Instituto Biodonostia, Universidad del País Vasco [UPV/EHU] and CIBERehd, San Sebastián, Spain.
  • Rivero M; Gastroenterology Units from Hospital Universitario Marqués de Valdecilla and IDIVAL, Santander, Spain.
  • Gomollón F; Gastroenterology Units from Hospital Clínico Universitario Lozano Blesa, IIS Aragón and CIBERehd, Zaragoza, Spain.
  • Benítez JM; Gastroenterology Units from Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Bermejo F; Gastroenterology Units from Hospital Universitario de Fuenlabrada and Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain.
  • Alcaide N; Gastroenterology Units from Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Gutiérrez A; Gastroenterology Units from Hospital General Universitario de Alicante and CIBERehd, Alicante, Spain.
  • Mañosa M; Gastroenterology Units from Hospital Germans Trials i Pujol and CIBERehd, Barcelona, Spain.
  • Iborra M; Gastroenterology Units from Hospital Universitario y Politécnico de La Fe and CIBERehd, Valencia, Spain.
  • Lorente R; Gastroenterology Units from Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
  • Rojas-Feria M; Gastroenterology Units from Hospital Universitario Nuestra Señora de Valme, Sevilla, Spain.
  • Barreiro-de Acosta M; Gastroenterology Units from Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
  • Kolle L; Gastroenterology Units from Hospital General de La Palma, La Palma, Spain.
  • Van Domselaar M; Gastroenterology Units from Hospital Universitario de Torrejón, Madrid, Spain.
  • Amo V; Gastroenterology Units from Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Argüelles F; Gastroenterology Units from Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Ramírez E; Gastroenterology Units from Pharmacy Unit, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain.
  • Morell A; Gastroenterology Units from Pharmacy Unit, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain.
  • Bernardo D; Gastroenterology Units from Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa [IIS-IP] and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas [CIBERehd], Madrid, Spain.
  • Gisbert JP; Gastroenterology Units from Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa [IIS-IP] and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas [CIBERehd], Madrid, Spain.
J Crohns Colitis ; 13(11): 1380-1386, 2019 Oct 28.
Article in En | MEDLINE | ID: mdl-30976785
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Inflammatory Bowel Diseases / Infliximab / Antibodies, Monoclonal Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Crohns Colitis Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Inflammatory Bowel Diseases / Infliximab / Antibodies, Monoclonal Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Crohns Colitis Year: 2019 Document type: Article